Literature DB >> 11577126

High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma.

H J Baelde1, A M Cleton-Jansen, H van Beerendonk, M Namba, J V Bovée, P C Hogendoorn.   

Abstract

AIMS: High quality RNA isolation from cartilaginous tissue is considered difficult because of relatively low cellularity and the abundance of extracellular matrix rich in glycosaminoglycans and collagens. Given the growing interest and technical possibilities to study RNA expression at a high throughput level, research on tissue with these characteristics is hampered by the lack of an efficient method for obtaining sufficient amounts of high quality RNA.
METHODS: This paper presents a robust protocol combining two RNA isolation procedures, based on a combination of Trizol and RNA specific columns, which has been developed to obtain high molecular weight RNA from fresh frozen and stored tissue of normal cartilage and cartilaginous tumours. Using this method, RNA was isolated from normal cartilage, peripheral chondrosarcoma, and central chondrosarcoma.
RESULTS: The yields ranged from 0.1 to 0.5 microg RNA/mg tissue. RNA isolated with this method was stable and of high molecular weight. RNA samples from normal cartilage and from two chondrosarcomas isolated using this method were applied successfully in cDNA microarray experiments. The number of genes that give interpretable results was in the range of what would be expected from microarray results obtained on chondrosarcoma cell line RNA. Signal to noise ratios were good and differential expression between tumour and normal cartilage was detectable for a large number of genes.
CONCLUSION: With this newly developed isolation method, high quality RNA can be obtained from low cellular tissue with a high extracellular matrix component. These procedures can also be applied to other tumour material.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577126      PMCID: PMC1731295          DOI: 10.1136/jcp.54.10.778

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.

Authors:  M A Bernard; D A Hogue; W G Cole; T Sanford; M B Snuggs; D Montufar-Solis; P J Duke; D D Carson; A Scott; W B Van Winkle; J T Hecht
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

Review 2.  Microarrays under the microscope.

Authors:  S E Wildsmith; F J Elcock
Journal:  Mol Pathol       Date:  2001-02

3.  EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.

Authors:  L Legeai-Mallet; A Rossi; C Benoist-Lasselin; R Piazza; J F Mallet; A L Delezoide; A Munnich; J Bonaventure; L Zylberberg
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

4.  Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.

Authors:  J V Bovée; A M Cleton-Jansen; N J Kuipers-Dijkshoorn; L J van den Broek; A H Taminiau; C J Cornelisse; P C Hogendoorn
Journal:  Genes Chromosomes Cancer       Date:  1999-11       Impact factor: 5.006

5.  Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.

Authors:  J V Bovée; L J van den Broek; A M Cleton-Jansen; P C Hogendoorn
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

Review 6.  New perspectives on the molecular basis of hereditary bone tumours.

Authors:  C McCormick; G Duncan; F Tufaro
Journal:  Mol Med Today       Date:  1999-11

7.  Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.

Authors:  J V Bovée; M van Royen; A F Bardoel; C Rosenberg; C J Cornelisse; A M Cleton-Jansen; P C Hogendoorn
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

9.  Use of a cDNA microarray to analyse gene expression patterns in human cancer.

Authors:  J DeRisi; L Penland; P O Brown; M L Bittner; P S Meltzer; M Ray; Y Chen; Y A Su; J M Trent
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

10.  Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization.

Authors:  R P van Gijlswijk; H J Zijlmans; J Wiegant; M N Bobrow; T J Erickson; K E Adler; H J Tanke; A K Raap
Journal:  J Histochem Cytochem       Date:  1997-03       Impact factor: 2.479

View more
  26 in total

1.  A new strategy to amplify degraded RNA from small tissue samples for microarray studies.

Authors:  Charlie C Xiang; Mei Chen; Li Ma; Quang N Phan; Jason M Inman; Olga A Kozhich; Michael J Brownstein
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  The glucose-induced synthesis of insulin in liver.

Authors:  Rajeshwary Ghosh; Soumendra K Karmohapatra; Gorachand Bhattacharya; A Kumar Sinha
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays.

Authors:  Antje Koppelkamm; Benedikt Vennemann; Sabine Lutz-Bonengel; Tony Fracasso; Marielle Vennemann
Journal:  Int J Legal Med       Date:  2011-05-17       Impact factor: 2.686

4.  Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade.

Authors:  Sandra Sampl; Sibylle Pramhas; Christian Stern; Matthias Preusser; Christine Marosi; Klaus Holzmann
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

5.  The effects of protein solubility on the RNA Integrity Number (RIN) for recombinant Escherichia coli.

Authors:  Mary Alice Salazar; Lawrence P Fernando; Faraz Baig; Sarah W Harcum
Journal:  Biochem Eng J       Date:  2013-10-15       Impact factor: 3.978

6.  Gelatin microspheres releasing transforming growth factor drive in vitro chondrogenesis of human periosteum derived cells in micromass culture.

Authors:  Abhijith K Kudva; Anna D Dikina; Frank P Luyten; Eben Alsberg; Jennifer Patterson
Journal:  Acta Biomater       Date:  2019-03-21       Impact factor: 8.947

7.  Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Authors:  Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway.

Authors:  Qingtang Miao; Sibin Hao; Hongmei Li; Fang Sun; Xueling Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  The albino chick as a model for studying ocular developmental anomalies, including refractive errors, associated with albinism.

Authors:  Jodi Rymer; Vivian Choh; Shrikant Bharadwaj; Varuna Padmanabhan; Laura Modilevsky; Elizabeth Jovanovich; Brenda Yeh; Zhan Zhang; Huanxian Guan; W Payne; Christine F Wildsoet
Journal:  Exp Eye Res       Date:  2007-06-21       Impact factor: 3.467

10.  Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.

Authors:  A-M Cleton-Jansen; J K Anninga; I H Briaire-de Bruijn; S Romeo; J Oosting; R M Egeler; H Gelderblom; A H M Taminiau; P C W Hogendoorn
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.